Analysis of the Global Stem Cell Market

LONDON, March 31, 2015 /PRNewswire/ -- This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the North America, Europe and APAC, followed by a detailed Asia Pacific Region Analysis, which covers countries such as India, Australia, Thailand, Singapore, South Korea, Malaysia and Japan. The stem cell market is covered into four broad segments, namely by products, by technology and by application. The study covers various areas of interest such as regulatory policies within stem cell research, key business updates, analysis of risk factors, and strategic recommendations. Additionally, key clinical milestones, timelines of key clinical events, key companies to watch, and a strategic partnership assessment in the global stem cell market have been included.

Key Findings
-The global market for stem cell was $ billion in 2013 and is expected to reach $ billion in 2018, growing at a robust CAGR of% from 2013 to 2018.
-The worldwide market for adult stem cell is estimated to be at $billion in 2013 and is projected to reach $ billion by 2018. Adult stem cells constitute % of the total stem cell market.
-Cord blood banking is one of the fastest growing segments of the stem cell market. The number of active cord blood banks worldwide have grown from mere in 2005 to over in 2013.
-North America's total stem cell market was valued at $ billion in 2013 and is projected to increase to $ billion by 2018.
-The European stem cell market was valued at $billion in 2013 and is projected to increase to $billion by 2018.
-The Asia-Pacific (APAC) stem cell market was valued at $ billion in 2013 and is projected to increase to $billion by 2018.
-APAC countries are progressing fast in the field of various stem cells research, including human embryonic stem cells, induced pluripotent stem cell (IPSc) and others. The major hurdle has been the regulatory environment in these countries, but that has been changing lately. Several Asian countries have modified their regulations regarding stem cell research to attract more investors.
-India, Singapore and South Korea are the frontrunners and are expected to dominate the APAC stem cells market in the coming years. Favourable regulatory changes and funding support from governments have helped the commercialization of the stem cells industry.
-Indian stem cell market was estimated to be $ million in 2013 and is expected to grow at a CAGR of % from 2013 to 2018.
-Current penetration of stem cell banking in Singapore is % and is expected to grow at a CAGR of % in next years.
-South Korea is all set to lead the stem cell research in APAC. Funding in stem cell in this country could be compared to that of US.
-Stem cells obtained from adult organisms constitute the main focus of research and the ethics surrounding the use of these cells are quite undisputed. Therapies employing adult stem cells are being developed by various companies (such as ViaCell, StemSource, Osiris Therapeutics, Neural Stem, and Angioblast) and are moving fast from laboratory to the clinical application phase.
-Majority of companies pursuing stem cell therapeutics are engaged in the development of adult stem cells derived from sources such as bone marrow, neural tissue, adipose tissue, menstrual blood, and placenta.
Download the full report: https://www.reportbuyer.com/product/2414037/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com